394 related articles for article (PubMed ID: 31667604)
1. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?
Joncour A; Puyade M; Michaud A; Tourani JM; Cazenave-Roblot F; Rammaert B
Support Care Cancer; 2020 Jul; 28(7):3103-3111. PubMed ID: 31667604
[TBL] [Abstract][Full Text] [Related]
2. Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies.
Puerta-Alcalde P; Cardozo C; Suárez-Lledó M; Rodríguez-Núñez O; Morata L; Fehér C; Marco F; Del Río A; Martínez JA; Mensa J; Rovira M; Esteve J; Soriano A; Garcia-Vidal C
Clin Microbiol Infect; 2019 Apr; 25(4):447-453. PubMed ID: 30096417
[TBL] [Abstract][Full Text] [Related]
3. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study.
Wang L; Wang Y; Fan X; Tang W; Hu J
Medicine (Baltimore); 2015 Nov; 94(45):e1931. PubMed ID: 26559260
[TBL] [Abstract][Full Text] [Related]
5. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
[TBL] [Abstract][Full Text] [Related]
6. Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.
Le Clech L; Talarmin JP; Couturier MA; Ianotto JC; Nicol C; Le Calloch R; Dos Santos S; Hutin P; Tandé D; Cogulet V; Berthou C; Guillerm G
Infect Dis (Lond); 2018 Jul; 50(7):539-549. PubMed ID: 29451055
[TBL] [Abstract][Full Text] [Related]
7. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
[TBL] [Abstract][Full Text] [Related]
8. Analysis of blood stream infections, antibiograms and clinical outcomes in haematological patients with febrile neutropenia: data from a tertiary care haematology institute in India.
Ghosh S; Chakraborty M; Samanta S; Sinha N; Saha S; Chattopadhyay A; Roy SS; Bhattacharyya M
Ann Hematol; 2021 Feb; 100(2):395-403. PubMed ID: 33140134
[TBL] [Abstract][Full Text] [Related]
9. The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies.
Calik S; Ari A; Bilgir O; Cetintepe T; Yis R; Sonmez U; Tosun S
Saudi Med J; 2018 Sep; 39(9):878-885. PubMed ID: 30251730
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia.
Castagnola E; Caviglia I; Pescetto L; Bagnasco F; Haupt R; Bandettini R
Future Microbiol; 2015; 10(3):357-64. PubMed ID: 25812459
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of bloodstream infection pathogens in hemato-oncological patients and predictors of carbapenem-resistant gram-negative bacterial infections during febrile neutropenia.
Schonardie AP; Beck E; Rigatto MH
Braz J Infect Dis; 2023; 27(2):102758. PubMed ID: 36809849
[TBL] [Abstract][Full Text] [Related]
12. Trends in bacterial bloodstream infections and resistance in immuno-compromised patients with febrile neutropenia: a retrospective analysis.
Raad C; Behdenna A; Fuhrmann C; Conter C; Cuzzubbo D; Rasigade JP; Bertrand Y; Domenech C
Eur J Pediatr; 2021 Sep; 180(9):2921-2930. PubMed ID: 33835249
[TBL] [Abstract][Full Text] [Related]
13. An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality.
Kara Ali R; Surme S; Balkan II; Salihoglu A; Sahin Ozdemir M; Ozdemir Y; Mete B; Can G; Ar MC; Tabak F; Saltoglu N
Ann Hematol; 2020 Aug; 99(8):1925-1932. PubMed ID: 32564194
[TBL] [Abstract][Full Text] [Related]
14. Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
Kleinhendler E; Cohen MJ; Moses AE; Paltiel O; Strahilevitz J; Cahan A
Int J Antimicrob Agents; 2018 Jan; 51(1):71-76. PubMed ID: 28705670
[TBL] [Abstract][Full Text] [Related]
15. Resistance to empirical β-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study.
Chumbita M; Puerta-Alcalde P; Yáñez L; Cuesta MA; Chinea A; Español Morales I; Fernández Abellán P; Gudiol C; Guerreiro M; González-Sierra P; Rojas R; Sánchez Pina JM; Sánchez Vadillo I; Varela R; Vázquez L; Lopera C; Monzó P; Garcia-Vidal C
J Antimicrob Chemother; 2022 Jun; 77(7):2017-2023. PubMed ID: 35466357
[TBL] [Abstract][Full Text] [Related]
16. Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia--species distribution and susceptibility patterns.
Miedema KG; Winter RH; Ammann RA; Droz S; Spanjaard L; de Bont ES; Kamps WA; van de Wetering MD; Tissing WJ
Support Care Cancer; 2013 Sep; 21(9):2417-26. PubMed ID: 23579946
[TBL] [Abstract][Full Text] [Related]
17. Bloodstream infections in neutropenic cancer patients: A practical update.
Gustinetti G; Mikulska M
Virulence; 2016 Apr; 7(3):280-97. PubMed ID: 27002635
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of antibiotic short course for bloodstream infections in acute myeloid leukemia patients with febrile neutropenia: A retrospective comparative study.
Metais A; Torregrosa Diaz JM; Gallego Hernanz MP; Pichon M; Desmier D; Roblot F; Rammaert B
J Infect; 2022 Jan; 84(1):1-7. PubMed ID: 34715238
[TBL] [Abstract][Full Text] [Related]
19. Early versus late onset bloodstream infection during neutropenia after high-dose chemotherapy for hematologic malignancy.
Widmer AF; Kern WV; Roth JA; Dettenkofer M; Goetting T; Bertz H; Theilacker C;
Infection; 2019 Oct; 47(5):837-845. PubMed ID: 31187401
[TBL] [Abstract][Full Text] [Related]
20. Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study).
Albasanz-Puig A; Gudiol C; Puerta-Alcalde P; Ayaz CM; Machado M; Herrera F; Martín-Dávila P; Laporte-Amargós J; Cardozo C; Akova M; Álvarez-Uría A; Torres D; Fortún J; García-Vidal C; Muñoz P; Bergas A; Pomares H; Mercadal S; Durà-Miralles X; García-Lerma E; Pallarès N; Carratalà J
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0004521. PubMed ID: 33972253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
